Lv61
2720 积分 2023-01-28 加入
Design, conduct, and interpretation of human mass balance studies and strategies for assessing metabolites-in-safety testing (MIST) in drug development
14天前
已完结
Applications of Quantitative Whole‐Body Autoradiography (QWBA) in Drug Discovery and Development
14天前
已完结
Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development
17天前
已完结
An evaluation of first-in-human studies for RNA oligonucleotides
17天前
已完结
Applications of humsn pharmacokinetic prediction in first-in-human dose estimation
17天前
已关闭
Preclinical Assessment of the PI3Kα Selective Inhibitor Inavolisib and Prediction of Its Pharmacokinetics and Efficacious Dose in Human
1个月前
已完结
Precise Modulation of Protein Degradation by Smart PROTACs
1个月前
已完结
Safety assessment of drug impurities for patient safety: a comprehensive review
1个月前
已完结
Industry Perspective on First-in-Human and Clinical Pharmacology Strategies to Support Clinical Development of T-Cell Engaging Bispecific Antibodies for Cancer Therapy
2个月前
已完结
Drug Transporters in Drug Disposition - Highlights from the Year 2023
2个月前
已完结
皖公网安备34019202002308
